Cancer Patients Alliance is a 501(c)(3) non-profit. Initiatives include Pancreatica.org, ToFightCancer.com, PancreaticCancerAlliance.org, and CancerPatientsAlliance.org.

All DONATIONS are tax-deductible.

These are unprecedented times where everything feels harder. Pancreatic cancer patients and families still need you.

Make an impact today, that lasts a lifetime.

Previous

Next

You have likely found us either because you have pancreatic cancer, or care about someone who does. Our mission is to promote awareness, increase education, and further pancreatic cancer research aimed at early diagnosis.

Click Here to Contact us

Pancreatic cancer is the 3rd leading cause of cancer-related death in the U.S. It is expected to become the 2nd leading cause of cancer-related death by the year 2020. We need to find the disease earlier!

Donate to Research

Our aim is to present impartial knowledge about pancreatic cancer whereby interested parties can access the range of existing treatment options, to aid patient/doctor partnerships, and thus help medical teams optimize personal treatment strategies.

Click Here to Support the Cause

Pancreatic cancer is the most aggressive of the major cancers, and the least funded. It is nearly always diagnosed too late with 80% of pancreatic cancer patients having a terminal disease.

Click Here to make a tax-deductible Donation

Together we can make a difference! Recently, a seasoned specialist told us that we had the highest social good to donation ratio that they had ever seen in any non-profit. We put all donations to serious use.

Click Here to find ways to Help or Donate

Pancreatic cancer is very aggressive. Fortunately together, so are we. There are many ways in which you can help the fight and make an impact for pancreatic cancer. Find the best way for you by clicking the link below.

Click Here to find ways to Help or Donate

Previous

Next

Author Archives: pancreatica

Abraxane and Gemcitabine for Advanced Pancreatic Cancer

By pancreatica | Published May 14, 2020

One of our favorite pancreatic cancer researchers, Dr. Daniel Von Hoff of TGen in Arizona – together with researchers from the Virginia G Piper Cancer Center – is reporting encouraging clinical trials results for those with advanced pancreatic cancer (ductal adenocarcinoma of the pancreas) treated with a combination of Abraxane plus gemcitabine. Neufachivife . This […]

Posted in Pancreatic Cancer Stories | Comments Off

High Dose Enzyme Therapy

By pancreatica | Published March 3, 2020

Jon Barron Tweet Alternative cancer protocols use high-dose enzyme therapy to break down tumors, sweep the circulatory system of debris, and stimulate immune function. Systemic enzymes, used in these protocols, break down the protective coating of viruses, liberating them so they can be identified and attacked by the immune system. Viruses and other pathogenic microorganisms […]

Posted in Pancreatic Cancer Stories | Comments Off

Pancreatic cancer ‘time machine’ exposes plot twist in cell growth and invasion

By pancreatica | Published February 17, 2020

Pancreatic cancer has one of the worst survival rates among cancers. Patients can expect as low as a 9% chance to live for at least five years after being diagnosed. Going back in time to observe how cells with key gene mutations interact and become invasive would help researchers better understand how the cancer starts and identify it sooner. […]

Posted in Pancreatic Cancer Stories | Comments Off